Available datapackage for study 'ONO-4538 Phase III Study A Multicenter, Randomized, Open-label Study in Patients With Esophageal Cancer Refractory or Intolerant to Combination Therapy With Fluoropyrimidine and Platinum-based Drugs'
收藏DataCite Commons2025-07-09 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00009925.0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of study is to evaluate the efficacy and safety of Nivolumab in unresectable
advanced or recurrent esophageal cancer patients who have failed in standard chemotherapies.
提供机构：
Vivli
创建时间：
2025-07-09
